Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Gastroenterology

Journal Scan / Research · December 11, 2019

Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With IBS With Diarrhea

The American Journal of Gastroenterology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The American Journal of Gastroenterology
Lactulose Breath Testing as a Predictor of Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
Am. J. Gastroenterol 2019 Dec 01;114(12)1886-1893, A Rezaie, Z Heimanson, R McCallum, M Pimentel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading